InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: trader59 post# 26196

Tuesday, 10/13/2020 11:13:04 AM

Tuesday, October 13, 2020 11:13:04 AM

Post# of 44690
EAP was 21 treated + 30 untreated with data in today's top line PR. Great success.
I still dont think anyone has access to the current IV data, see masking. IV Trial will need to complete for that Data. IMO. So, this top line data will be also sent for Emergency Use application. 144 patient data to be evaluated by Outcome Assessors at the completion. 30 patient safety/futility done and (agreed on) 102 review next step till full Trial completion.
Nice bump this AM, will we see the Volume needed to hold and gain?

Estimated Enrollment : 144 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Multicenter trial, initially conducted at a single center with a safety/futility assessment following enrollment of 30 patients
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description: Randomized, placebo-controlled trial with identical drug and placebo infusion bags